Ahead of World Diabetes Day 2022, P&G Health brought together globally renowned multidisciplinary medical experts with Healthcare Professionals from across Asia-Pacific and the Middle East, at the ‘Winning the Fight Against Neuropathy in Diabetic Patients’ forum to share the latest clinical guidance on diagnosing and treating diabetic nerve damage.
With Diabetes Mellitus being the leading cause of peripheral neuropathy (PN), the increasing prevalence of PN is closely linked to the rise in the number of diabetic patients. PN including Diabetic Peripheral Neuropathy (DPN) is the result of damage to the nerves impacting quality of life of people as they are not able to go about their daily lives as comfortably’
Dr Ashley Barlow, Senior Director, Medical & Technical Affairs, P&G Health (Asia Pacific, India, Middle East, and Africa) shared, “As a partner to International Diabetes Federation (IDF), P&G Health is committed to continued efforts to raise awareness on Diabetes and its associated complications including Peripheral Neuropathy and Nerve Damage. The ‘Winning the Fight Against Neuropathy in Diabetic Patients’ forum is the first of several scientific forums being rolled out by P&G Health as part of our World Diabetes Day awareness efforts across Asia Pacific, Middle East, and Africa region, to highlight the connection between Peripheral Neuropathy and Diabetes and the importance of early identification and timely treatment.”
Dr. Rayaz A. Malik Professor of Medicine at Weill Cornell Medicine, shared, “Peripheral neuropathy is highly underdiagnosed in South-East Asia and the Middle East due to a lack of consensus guidance on routine screening and diagnostic pathways. This has a major impact on the quality of life as a result of painful neuropathic symptoms, foot ulceration and amputation with an associated 5-year mortality of 40% and 80%, respectively. An awareness and sense of urgency amongst patients and healthcare providers is required, and primary care physicians need simple tools and guidance to help them diagnose peripheral neuropathy.”
“While identifying a patient with early onset PN may sound challenging, it is not and doesn’t require complex diagnostic tools to diagnose peripheral neuropathy. Simple tools like a questionnaire and a sensory test can be a good start. By asking the right questions and listening to the patient, we can help patients avoid severe complications and improve their quality of life. The primary care physician has a key role to play in this,” added Dr. Malik.
